Safeguard scientifics inc (SFE)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Changes in assets and liabilities:
Net cash used in operating activities

-2,551

-1,427

-6,362

-6,399

-5,782

-7,386

-5,036

-6,839

-6,774

-5,290

-4,108

-4,866

-6,541

-4,547

-3,271

-5,003

-5,840

-3,663

-2,841

-4,764

-6,481

-4,714

-2,697

-4,962

-7,816

-4,922

-4,759

-4,649

-6,891

-3,909

-2,992

-2,930

-6,694

-4,143

-3,192

-3,107

-7,285

Cash Flows from Investing Activities:
Proceeds from sales of and distributions from ownership interests

708

3,112

1,866

57,546

41,778

-2,525

55,000

11,655

3,257

0

142

709

15,753

111

1,030

68,630

4,194

29

13,650

9,187

2,192

1,196

423

4,016

77,187

36,371

1,200

60

1,343

3,070

3,465

10,984

77

101

33,176

137,896

95

Acquisitions of ownership interest

1,000

-

-

-

-

-

-

-

-

3,250

3,825

3,550

4,476

17,590

6,512

11,256

17,073

18,005

11,636

26,416

14,129

4,520

29,550

20,045

5,361

13,120

13,587

5,345

9,786

24,381

5,529

129

16,061

10,637

15,584

45,035

14,073

Advances and loans

1,241

101

336

693

3,925

1,006

4,149

3,913

4,036

5,934

3,369

7,135

6,429

10,226

7,590

3,032

7,119

4,273

0

2,597

8,338

1,100

2,250

7,090

528

1,114

1,250

2,984

5,116

350

8,174

2,070

3,071

-

-

-

-

Repayment of advances and loans

-

-

-

-

-

78

152

0

10,500

0

0

0

0

0

1,685

28

28

28

1,235

27

28

-825

1,412

2,135

1,962

607

116

928

0

0

70

750

2,394

-

-

-

-

Origination fees on mezzanine loans

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28

0

46

-

-

-

-

Purchases of marketable securities

-

0

0

0

57,243

12,951

24,858

0

0

-

-

-

-

-

-

-

-

5,880

7,112

7,426

9,337

11,016

20,704

7,474

16,400

22,811

17,159

8,402

21,511

32,147

67,879

96,517

45,480

80,335

89,643

14,754

55,635

Proceeds from sales and maturities in marketable securities

-

0

25,000

7,954

62,235

3,937

440

2,361

1,410

969

0

0

10,268

10,929

5,129

3,655

26,602

5,597

11,367

7,861

8,815

15,431

5,535

15,530

18,914

35,715

37,112

39,647

52,905

50,259

92,382

58,133

75,618

42,087

13,239

33,586

19,481

Capital expenditures

-

-

-

-

-

-

-

-

-

-

-

-

-

359

0

51

22

1,454

158

134

110

48

0

0

11

0

16

7

14

48

0

18

7

-

-

-

-

Proceeds from sale of discontinued operations, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1

Other, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-132

0

0

-5

6,392

0

-6,434

0

-

-

-

-

1

-1

0

-107

Net cash (used in) provided by investing activities

-1,533

1,621

23,030

58,807

42,845

-12,467

23,586

9,853

11,131

-8,215

-7,052

-9,976

15,116

-19,532

-10,387

43,370

6,610

-23,958

7,346

-19,498

-20,879

-750

-45,134

-12,928

75,768

35,648

6,416

30,373

17,821

4,104

14,363

-28,867

13,516

-57,224

-56,263

110,936

-50,024

Cash Flows from Financing Activities:
Repurchase of convertible senior debentures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

30,848

Issuance of Company common stock, net

-

-

-

-

-

-

-

-

-

-

0

2

10

0

5

0

0

0

127

0

549

677

39

51

522

20

4,305

0

92

176

1,055

374

139

313

259

202

144

Tax withholdings related to equity-based awards

11

26

30

31

149

33

34

50

150

48

45

30

100

23

82

355

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repurchase of Company common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-56

5,445

3,249

1,748

0

0

0

0

16,996

8,040

122

0

0

0

-

-

-

-

-

-

-

-

Net cash used in financing activities

-11

-20,705

-44,574

-24,055

-149

-16,466

-34

-8,302

-150

-61

-2,704

32,480

-90

-23

-77

-299

-5,445

-3,249

-1,621

0

549

677

39

-17,386

-7,518

-102

4,305

-43

92

-5,317

1,055

374

139

313

259

202

-30,704

Net change in cash, cash equivalents and restricted cash

-4,095

-20,511

-27,906

28,353

36,914

-36,319

18,516

-5,288

4,207

-13,566

-13,864

17,638

8,485

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net change in cash, cash equivalents and restricted cash equivalents

-4,095

-20,511

-27,906

28,353

36,914

-36,319

18,516

-5,288

4,207

-13,566

-13,864

17,638

8,485

-24,102

-13,735

38,068

-4,675

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net change in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,884

-24,262

-26,811

-

-47,792

-35,276

60,434

30,624

5,962

25,681

11,022

-5,122

12,426

-31,423

6,961

-61,054

-59,196

108,031

-88,013